Watch Ticker

Rapport Therapeutics, Inc. Common Stock

Go to Rapport Therapeutics, Inc. Common Stock Website

$14.63

0.21 (1.42%)

Live

Previous Close

$14.43

Day Range

$14.0301 - $15.88

Previous Day Range

$13.87 - $15.2

Market Cap

$512.4 million USD

Day Vol.

18779

Previous Day Vol.

206792

Currency

USD

Primary Exchange

None

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucid...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Marketbeat.Com - Analysts Can't Get Enough of These Little-Known Biopharma Stocks

Analysts are bullish on several little-known biopharma stocks, including Kymera Therapeutics, Vera Therapeutics, and Rapport Therapeutics, due to promising drug candidates and strong financial positions.

Related tickers: KYMR, VERA, RAPP.

Read Full Article

Rapport Therapeutics, Inc. - Rapport Therapeutics Hosts Investor and Analyst Day; Provides Corporate Updates

Rapport Therapeutics announced that its Phase 2a trial of RAP-219 for refractory focal epilepsy is fully enrolled and on track to report topline results in September 2025. The company also provided updates on the RAP-219 development program and its financial position.

Related tickers: RAPP.

Read Full Article

Trending Tickers

Please sign in to view